Abstract PS5-12-19: Pre-ispy trial: a phase i/ib oncology platform program (pre-i-spy-p1) nct05868226
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: P. R. POHLMANN, D. A. Potter, N. Chen, N. Jahan, J. A. Mouabbi, H. S. Han, J. R. Diamond, M. Bhave, M. Rampurwala, S. Rayani, A. Discacciati, M. Eklund, A. G. Chappel, A. L. Delson, B. K. LeStage, C. Hendricks-Kretzer, S. Venters, L. Brown-Swigart, G. L. Hirst, E. Petricoin, A. D. Borowsky, L. J. van 't Veer, S. M. Asare, S. Jafari, P. Henderson, D. Tripathy, H. Rugo, R. Nanda, E. Stringer-Reasor, D. Yee, F. Meric-Bernstam, L. J. Esserman
Institutions: The University of Texas MD Anderson Cancer Center, University of Minnesota, Masonic Cancer Center, University of Chicago, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Moffitt Cancer Center, University of Colorado Anschutz, Emory University, Winship Cancer Institute, University of Chicago Medical Center, Silver Cross Hospital, Karolinska Institutet, Quantum Leap Healthcare Collaborative, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, George Mason University, University of California Davis Medical Center, University of California, Davis, City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7129498205
Cites:
Cited by:
Related to: